Your partner for radiopharmaceutical development and imaging trials

TRACER offers an integrated range of services for preclinical and in-human studies (Phase 0, 1, and 2) for radiopharmaceuticals and radiolabeled drugs. Our expertise allows us to answer highly specific questions regarding your development program, including CMC, dosimetry calculations, clinical trial design, and regulatory approval.

The development of radiopharmaceuticals requires specialized expertise across various disciplines. To conduct studies efficiently, radioisotope production, manufacturing, and clinical sites trained and equipped for clinical trials with radiopharmaceuticals are required.

TRACER, a contract research organisation specialized in radiopharmaceutical development and nuclear imaging trials, combines such expertise with an established network of clinical sites. This means our services cover every aspect you will encounter throughout the development process.